222 related articles for article (PubMed ID: 22009136)
1. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.
Disertori M; Barlera S; Staszewsky L; Latini R; Quintarelli S; Franzosi MG
Cardiovasc Drugs Ther; 2012 Feb; 26(1):47-54. PubMed ID: 22009136
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews.
Yu Z; Zhang D; Ji Q; Yi F
Medicine (Baltimore); 2021 May; 100(18):e25559. PubMed ID: 33950930
[TBL] [Abstract][Full Text] [Related]
3. Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials.
Bhuriya R; Singh M; Sethi A; Molnar J; Bahekar A; Singh PP; Khosla S; Arora R
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):178-84. PubMed ID: 21285399
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
Huang CY; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
Heart; 2018 Aug; 104(15):1276-1283. PubMed ID: 29371376
[TBL] [Abstract][Full Text] [Related]
7. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL
Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347
[TBL] [Abstract][Full Text] [Related]
8. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis.
Jibrini MB; Molnar J; Arora RR
Am J Ther; 2008; 15(1):36-43. PubMed ID: 18223352
[TBL] [Abstract][Full Text] [Related]
9. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
10. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials.
Han M; Zhang Y; Sun S; Wang Z; Wang J; Xie X; Gao M; Yin X; Hou Y
J Cardiovasc Pharmacol; 2013 Oct; 62(4):405-15. PubMed ID: 23921300
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
[TBL] [Abstract][Full Text] [Related]
15. Effect of sacubitril-valsartan on the incidence of atrial fibrillation: A meta-analysis.
Mohammad Z; Ahmad J; Sultan A; Penagaluri A; Morin D; Dominic P
J Cardiovasc Electrophysiol; 2023 Apr; 34(4):1037-1042. PubMed ID: 36871177
[TBL] [Abstract][Full Text] [Related]
16. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
17. Association of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists use with risk of atrial fibrillation after pacemaker implantation among very old patients.
Lin D; Wu C; Jiang Y; Li Y; Zhang X; Wang Y
Biosci Trends; 2022 Jan; 15(6):390-396. PubMed ID: 34866125
[TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.
Madrid AH; Peng J; Zamora J; Marín I; Bernal E; Escobar C; Muños-Tinoco C; Rebollo JM; Moro C
Pacing Clin Electrophysiol; 2004 Oct; 27(10):1405-10. PubMed ID: 15511250
[TBL] [Abstract][Full Text] [Related]
19. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
